Wesley Clark

French-American Foundation Names New York Lawyer Edward Wallace to Succeed Allan Chapin as Chair

Retrieved on: 
Thursday, July 6, 2023
State, FAF, Partnership, Wesley Clark, Chair, National security, Culture, Politics, Boston Properties, Peace Corps, French-American Foundation, UNICEF, Government, Goldman Sachs, BNP Paribas, Institution, Corporation, Management, Nursing, Atlantic Ocean

NEW YORK, July 6, 2023 /PRNewswire/ -- The French-American Foundation-US Board of Directors announced today the appointment of Edward C. Wallace as its Chair and Allan M. Chapin as its Chair Emeritus.

Key Points: 
  • NEW YORK, July 6, 2023 /PRNewswire/ -- The French-American Foundation-US Board of Directors announced today the appointment of Edward C. Wallace as its Chair and Allan M. Chapin as its Chair Emeritus.
  • "I am delighted that the Board has unanimously approved my friend and colleague, Ed Wallace, to be Chair.
  • Edward C. Wallace co-chairs the New York City office of Greenberg Traurig, one of the world's largest law firms.
  • On his appointment, Ed Wallace stated, "I have seen FAF make a difference when tensions rise across the Atlantic.

HDL Therapeutics Inc Plans to Become Publicly Traded via a Business Combination With $225 Million Swiftmerge (NASDAQ: IVCP) With Goal to Transform Cardiovascular Disease Treatment

Retrieved on: 
Monday, April 24, 2023
Cardiology, Biotechnology, Pharmaceutical, Finance, Health, Asset Management, Professional Services, Other Health, Plaque, Wesley Clark, Cardiovascular disease, Cedars-Sinai Medical Center, UCLA School of Nursing, Stroke, Splenic infarction, Dean, HDL, Atherosclerosis, LOI, Death, Rupture, IVCP, Acquisition, Patient, Risk, Nursing, FDA, Therapy, Pharmaceutical industry

HDL Therapeutics’ platform, removes the highest risk plaques in coronary arteries that tend to rupture causing heart attacks and stroke.

Key Points: 
  • HDL Therapeutics’ platform, removes the highest risk plaques in coronary arteries that tend to rupture causing heart attacks and stroke.
  • Cardiovascular disease, including heart attacks, are the leading cause of death worldwide, taking an estimated 17.9 million lives annually.
  • In the United States, heart attacks were responsible for 132,968 deaths, and almost half of American adults have cardiovascular diseases.
  • "This proposed business combination will be a significant milestone for HDL Therapeutics and a breakthrough in the development of a whole new treatment paradigm for a fatal cardiovascular disease."

General Wesley Clark Joins Vaya Space as Senior Board and Company Advisor

Retrieved on: 
Tuesday, February 14, 2023
Astronaut, White, Private sector, House, General Abrams, Institute for Space and Defense Electronics, Supreme Allied Commander Atlantic, Presidential Medal of Freedom, RET, Wesley Clark, Fire, University, White House, Parliament, Defense Distinguished Service Medal, Doorkeeper (Houses of Parliament), Army, United States Army, Plastic, Oxford, Communications satellite, Renewable energy, Defense, Vaya

COCOA, Fla., Feb. 14, 2023 (GLOBE NEWSWIRE) -- Vaya Space, Inc., the green Space and Defense company and emerging leader in performance, cost and sustainability, today announced that General Wesley K. Clark, USA, (Ret.)

Key Points: 
  • COCOA, Fla., Feb. 14, 2023 (GLOBE NEWSWIRE) -- Vaya Space, Inc., the green Space and Defense company and emerging leader in performance, cost and sustainability, today announced that General Wesley K. Clark, USA, (Ret.)
  • has joined Vaya Space as a senior advisor to the Board and Company to support investment in and expansion of Vaya Space's new technologies to the highly attractive Space (launch) and Defense (strategic and tactical missile) landscape.
  • Gen. Clark is a retired United States Army four-star general who last served as the Supreme Allied Commander in Europe of NATO .
  • Sid Gutierrez, Chairman of the Board of Vaya, former Space Shuttle Commander and the first U.S.-born Hispanic Astronaut commented, "First, General Abrams joining Vaya and now General Wesley Clark, says a tremendous amount about the Company, how far we have come, and how efficacious our technologies really are.

ImmunityBio Appoints John Brennan and Wesley Clark to Board of Directors

Retrieved on: 
Wednesday, February 24, 2021
Oncology, Health, General Health, Research, Pharmaceutical, Science, Orders, decorations, and medals, Awards, Articles, Patrick Soon-Shiong, Wesley Clark, Brennan, Board of directors, Wesley, John Brennan, Wesley Clark, Christobel Selecky, ImmunityBio

ImmunityBio, Inc ., a privately-held immunotherapy company, today announced the appointment of John Brennan, former Central Intelligence Agency Director, and Wesley Clark, retired U.S. Army General, to the companys board of directors, effective immediately.

Key Points: 
  • ImmunityBio, Inc ., a privately-held immunotherapy company, today announced the appointment of John Brennan, former Central Intelligence Agency Director, and Wesley Clark, retired U.S. Army General, to the companys board of directors, effective immediately.
  • With the appointment of Messrs. Brennan and Clark, the companys board expands to four directors, including Christobel Selecky, who was appointed to the board in August 2020, and Patrick Soon-Shiong, MD, Chairman and CEO of ImmunityBio.
  • All four directors are expected to serve on the combined board of ImmunityBio and NantKwest ( Nasdaq: NK ) upon completion of the pending merger.
  • We are excited to welcome John and Wesley to the ImmunityBio Board and look forward to benefiting from their significant international and government experience.